SEC Form 4 · accession 0001553878-15-000004
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Maraganore
Officer — Chief Executive Officer · Director
Period of report
Jan 26, 2015
Accepted (ET)
Jan 28, 2015 · 5:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 26, 2015 | P | 10,000 | $95.00 | A | 122,825 | D | |
| Common StockF2 | holding | — | — | — | 2,700 | I | By Managed Account |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The purchase reported on this Form 4 was made by the reporting person in connection with the Company's Public Offering of Common Stock.
- F2The reporting person owns 2,700 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.